MedTrace Logo

Prospective Evaluation of FibroScan in Patients Treated With Methotrexate

NCT00673101 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1871

Last updated 2019-07-05

No results posted yet for this study

Summary

The aim of this study is to evaluate liver fibrosis using FibroScan and biochemical markers in patients treated with methotrexate.

Conditions

  • Liver Fibrosis

Sponsors & Collaborators

  • Association HGE CHU Bordeaux Sud

    lead OTHER

Principal Investigators

  • Thierry Schaeverbeke, MD, PhD · University Hospital, Bordeaux

  • Edouard Chabrun, MD · Gastroenterology and Hepatology Unit, Haut-Lévêque Hospital, 33604 Pessac, France

  • Thomas Hubiche, MD · University Hospital, Bordeaux

  • Marie-Sylvie Doutre, MD, PhD · University Hospital, Bordeaux

  • Maïté Longy-Boursier, MD, PhD · CHU de Bodeaux

  • Jean-Luc Pellegrin, MD, PhD · University Hospital, Bordeaux

  • Juliette Foucher, MD · Gastroenterology and Hepatology Unit, Haut-Lévêque Hospital, 33604 Pessac, France

  • Franck Zerbib, MD PhD · Gastroenterology and Hepatology Unit, Saint-André Hospital, 33075 Bordeaux, Cedex, France

  • David Laharie, MD PhD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00673101 on ClinicalTrials.gov